Cyclooxygenase-2 inhibitors: promise or peril?
The discovery of two isoforms of the cyclooxygenase enzyme, COX-1 and COX-2, and the development of COX-2-specific inhibitors as anti-inflammatories and analgesics have offered great promise that the therapeutic benefits of NSAIDs could be optimized through inhibition of COX-2, while minimizing thei...
Saved in:
Main Authors: | Laurel J. Mengle-Gaw, Benjamin D. Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2002-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629350290000041 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The promises and perils of central bank digital currencies
by: Louis Larue, et al.
Published: (2020-12-01) -
The Promises and Perils of Nurse-Led Flexible Sigmoidoscopy Screening
by: Paul Moayyedi
Published: (2007-01-01) -
There May Be a Way to Say 'NO' to Gastric Injury Associated with the Combined Use of Aspirin and Cyclooxygenase-2 Inhibitors
by: Jennifer J Williams, et al.
Published: (2004-01-01) -
Cyclooxygenase Inhibitor Associated with Carboplatin in Treatment of Metastatic Nasal Carcinoma in Dog
by: Carlos Eduardo Fonseca-Alves, et al.
Published: (2014-01-01) -
Cyclooxygenase-2 and its regulation in inflammation
by: Y. S. Bakhle, et al.
Published: (1996-01-01)